VISCHER has advised Forty51 Ventures, a Biotech venture capital firm, on its first fund, Forty51 Ventures Fund I which has raised USD 43 million in a first closing and is domiciled in Luxemburg. VISCHER has supported,
Tags :life sciences
According to BarkerGilmore report, interesting in-house figures concern annual salary increase rates, gender pay trends and practice areas.